Loading…

SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors

Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP f...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion and apheresis science 2022-04, Vol.61 (2), p.103326-103326, Article 103326
Main Authors: Leon, Judith, Merrill, Anna E., Rogers, Kai, Kurt, Julie, Dempewolf, Spencer, Ehlers, Alexandra, Jackson, J. Brooks, Knudson, C. Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3
cites cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3
container_end_page 103326
container_issue 2
container_start_page 103326
container_title Transfusion and apheresis science
container_volume 61
creator Leon, Judith
Merrill, Anna E.
Rogers, Kai
Kurt, Julie
Dempewolf, Spencer
Ehlers, Alexandra
Jackson, J. Brooks
Knudson, C. Michael
description Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2> 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.
doi_str_mv 10.1016/j.transci.2021.103326
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473050221003268</els_id><sourcerecordid>2606922801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</originalsourceid><addsrcrecordid>eNqFkctq3DAUhkVpadKkj9CiZTee6mJdvGkJk14CgUCTZiuOZXmiwZZcyWPI20fDTEO66krinP_85_Ih9IGSFSVUft6u5gQhW79ihNES45zJV-iUaqUrKjV_Xf614hURhJ2gdzlvCaGKNvItOuG1lozW5BRNtxe_bqt1vK8YhjD7NnaP2D5A2LiMfcATzN6FOePkrPOLDxu8vrm_uqxog20MCwwu2yLA0wB5BNynOOIQ0whD8evwAtb6ALPrcBdLPJ-jNz0M2b0_vmfo9_dvd-uf1fXNj6v1xXVluWayslQTrqyyRFDasFaQvpGtEL1QNQBXQtayh5Y1trVNyxkXxAHUDPpOca5afoa-HHynXTu6bj9jgsFMyY-QHk0Eb_7NBP9gNnExWhItJSkGn44GKf7ZuTyb0ZdVhwGCi7tsmCSyYUwTWqTiILUp5pxc_9yGErOnZbbmSMvsaZkDrVL38eWMz1V_8RTB14PAlUst3iVTLFywrvOFx2y66P_T4gkSeqls</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2606922801</pqid></control><display><type>article</type><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><source>ScienceDirect Freedom Collection</source><creator>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</creator><creatorcontrib>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</creatorcontrib><description>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2&gt; 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</description><identifier>ISSN: 1473-0502</identifier><identifier>EISSN: 1878-1683</identifier><identifier>EISSN: 1473-0502</identifier><identifier>DOI: 10.1016/j.transci.2021.103326</identifier><identifier>PMID: 34862140</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibodies, Viral ; Blood Donors ; COVID-19 ; COVID-19 - therapy ; COVID-19 convalescent plasma (CCP) ; COVID-19 Serotherapy ; Humans ; Immunization, Passive ; SARS-CoV-2 ; Vaccinated donors</subject><ispartof>Transfusion and apheresis science, 2022-04, Vol.61 (2), p.103326-103326, Article 103326</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Ltd.</rights><rights>Published by Elsevier Ltd. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</citedby><cites>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</cites><orcidid>0000-0003-3964-5466 ; 0000-0002-5945-5937 ; 0000-0003-3331-5933</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34862140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leon, Judith</creatorcontrib><creatorcontrib>Merrill, Anna E.</creatorcontrib><creatorcontrib>Rogers, Kai</creatorcontrib><creatorcontrib>Kurt, Julie</creatorcontrib><creatorcontrib>Dempewolf, Spencer</creatorcontrib><creatorcontrib>Ehlers, Alexandra</creatorcontrib><creatorcontrib>Jackson, J. Brooks</creatorcontrib><creatorcontrib>Knudson, C. Michael</creatorcontrib><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><title>Transfusion and apheresis science</title><addtitle>Transfus Apher Sci</addtitle><description>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2&gt; 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</description><subject>Antibodies, Viral</subject><subject>Blood Donors</subject><subject>COVID-19</subject><subject>COVID-19 - therapy</subject><subject>COVID-19 convalescent plasma (CCP)</subject><subject>COVID-19 Serotherapy</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>SARS-CoV-2</subject><subject>Vaccinated donors</subject><issn>1473-0502</issn><issn>1878-1683</issn><issn>1473-0502</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkctq3DAUhkVpadKkj9CiZTee6mJdvGkJk14CgUCTZiuOZXmiwZZcyWPI20fDTEO66krinP_85_Ih9IGSFSVUft6u5gQhW79ihNES45zJV-iUaqUrKjV_Xf614hURhJ2gdzlvCaGKNvItOuG1lozW5BRNtxe_bqt1vK8YhjD7NnaP2D5A2LiMfcATzN6FOePkrPOLDxu8vrm_uqxog20MCwwu2yLA0wB5BNynOOIQ0whD8evwAtb6ALPrcBdLPJ-jNz0M2b0_vmfo9_dvd-uf1fXNj6v1xXVluWayslQTrqyyRFDasFaQvpGtEL1QNQBXQtayh5Y1trVNyxkXxAHUDPpOca5afoa-HHynXTu6bj9jgsFMyY-QHk0Eb_7NBP9gNnExWhItJSkGn44GKf7ZuTyb0ZdVhwGCi7tsmCSyYUwTWqTiILUp5pxc_9yGErOnZbbmSMvsaZkDrVL38eWMz1V_8RTB14PAlUst3iVTLFywrvOFx2y66P_T4gkSeqls</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Leon, Judith</creator><creator>Merrill, Anna E.</creator><creator>Rogers, Kai</creator><creator>Kurt, Julie</creator><creator>Dempewolf, Spencer</creator><creator>Ehlers, Alexandra</creator><creator>Jackson, J. Brooks</creator><creator>Knudson, C. Michael</creator><general>Elsevier Ltd</general><general>Pergamon, Elsevier Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3964-5466</orcidid><orcidid>https://orcid.org/0000-0002-5945-5937</orcidid><orcidid>https://orcid.org/0000-0003-3331-5933</orcidid></search><sort><creationdate>20220401</creationdate><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><author>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Viral</topic><topic>Blood Donors</topic><topic>COVID-19</topic><topic>COVID-19 - therapy</topic><topic>COVID-19 convalescent plasma (CCP)</topic><topic>COVID-19 Serotherapy</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>SARS-CoV-2</topic><topic>Vaccinated donors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leon, Judith</creatorcontrib><creatorcontrib>Merrill, Anna E.</creatorcontrib><creatorcontrib>Rogers, Kai</creatorcontrib><creatorcontrib>Kurt, Julie</creatorcontrib><creatorcontrib>Dempewolf, Spencer</creatorcontrib><creatorcontrib>Ehlers, Alexandra</creatorcontrib><creatorcontrib>Jackson, J. Brooks</creatorcontrib><creatorcontrib>Knudson, C. Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion and apheresis science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leon, Judith</au><au>Merrill, Anna E.</au><au>Rogers, Kai</au><au>Kurt, Julie</au><au>Dempewolf, Spencer</au><au>Ehlers, Alexandra</au><au>Jackson, J. Brooks</au><au>Knudson, C. Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</atitle><jtitle>Transfusion and apheresis science</jtitle><addtitle>Transfus Apher Sci</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>61</volume><issue>2</issue><spage>103326</spage><epage>103326</epage><pages>103326-103326</pages><artnum>103326</artnum><issn>1473-0502</issn><eissn>1878-1683</eissn><eissn>1473-0502</eissn><abstract>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2&gt; 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34862140</pmid><doi>10.1016/j.transci.2021.103326</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3964-5466</orcidid><orcidid>https://orcid.org/0000-0002-5945-5937</orcidid><orcidid>https://orcid.org/0000-0003-3331-5933</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-0502
ispartof Transfusion and apheresis science, 2022-04, Vol.61 (2), p.103326-103326, Article 103326
issn 1473-0502
1878-1683
1473-0502
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608660
source ScienceDirect Freedom Collection
subjects Antibodies, Viral
Blood Donors
COVID-19
COVID-19 - therapy
COVID-19 convalescent plasma (CCP)
COVID-19 Serotherapy
Humans
Immunization, Passive
SARS-CoV-2
Vaccinated donors
title SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A51%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20antibody%20changes%20in%20patients%20receiving%20COVID-19%20convalescent%20plasma%20from%20normal%20and%20vaccinated%20donors&rft.jtitle=Transfusion%20and%20apheresis%20science&rft.au=Leon,%20Judith&rft.date=2022-04-01&rft.volume=61&rft.issue=2&rft.spage=103326&rft.epage=103326&rft.pages=103326-103326&rft.artnum=103326&rft.issn=1473-0502&rft.eissn=1878-1683&rft_id=info:doi/10.1016/j.transci.2021.103326&rft_dat=%3Cproquest_pubme%3E2606922801%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2606922801&rft_id=info:pmid/34862140&rfr_iscdi=true